SEC Filing Summary: Tempur-Pedic International Inc. (10-Q)
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2004. Tempur-Pedic International Inc. is a vertically-integrated manufacturer and marketer of premium visco-elastic foam mattresses and pillows, operating in 54 countries. The company operates through two primary segments: Domestic (U.S. manufacturing and sales) and International (Denmark manufacturing and global distribution). The company completed its initial public offering (IPO) in December 2003.
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Net Sales | $153.1 million | $105.1 million |
| Gross Profit | $81.3 million | $57.6 million |
| Gross Margin | 53.1% | 54.8% |
| Operating Income | $30.5 million | $22.4 million |
| Net Income | $11.8 million | $10.9 million |
| Diluted EPS | $0.11 | $0.12 |
| Cash from Operations | $8.9 million | $4.5 million |
| Total Debt (Book Value) | $309.8 million | $376.5 million |
| Cash and Equivalents | $11.6 million | $5.4 million |
| Working Capital | $62.0 million | $55.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 45.7% year-over-year, driven primarily by a 58.5% increase in Domestic sales and a 29.5% increase in International sales. The Retail channel was the primary growth driver.
- Debt Reduction: The company redeemed $52.5 million of its 10.25% Senior Subordinated Notes in January 2004 using IPO proceeds. This resulted in a $5.4 million loss on extinguishment of debt, which reduced net income.
- Stock-Based Compensation: The company recorded $1.5 million in compensation expense related to pre-IPO stock options, impacting operating income.
- Margin Compression: Operating income margin decreased to 19.9% from 21.3% due to increased spending on information technology, Sarbanes-Oxley compliance costs, and the aforementioned non-recurring charges.
- EPS Dilution: Despite higher net income, diluted EPS decreased from $0.12 to $0.11 due to a significant increase in the weighted average number of shares outstanding following the IPO and stock split.
Guidance, Outlook, and Risks
- Capital Expenditures: The company expects 2004 capital expenditures to be approximately $28.0 million, including $16.0 million for the expansion of its European manufacturing facility and $0.8 million for U.S. facility expansion.
- Liquidity: The company maintains approximately $30.8 million in unused availability under its revolving credit facilities. Management intends to retain earnings to fund growth and does not anticipate paying dividends in the foreseeable future.
- Key Risks:
- Competition: Intense competition in the mattress and pillow industries, including from lower-priced alternatives.
- Customer Concentration: The top five customers accounted for 12.9% of sales; the loss of a significant customer could materially impact results.
- Regulatory: Potential new fire retardancy standards (e.g., in California) may increase costs.
- Supply Chain: Reliance on a limited number of suppliers for key raw materials (polyol) and outsourcing of cover manufacturing.
- Warranty and Returns: Risks associated with maintaining warranty reserves and managing return rates, particularly in the direct channel.
Investor Verification Checklist
- Verify the sustainability of the 45.7% revenue growth rate given the high base and competitive landscape.
- Monitor the impact of the $5.4 million debt extinguishment loss as a one-time event versus ongoing debt service costs.
- Assess the adequacy of warranty reserves ($3.8 million) and sales return accruals ($5.6 million) given the 20-year warranty terms and 90-day return policy.
- Review the progress and cost overruns of the $28 million planned capital expenditures for manufacturing expansion.
- Track the company's ability to maintain gross margins amidst potential raw material cost fluctuations and new regulatory compliance costs.